Full Text View
Tabular View
No Study Results Posted
Related Studies
Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)
This study has been completed.
Study NCT00862589   Information provided by University Hospital, Gentofte, Copenhagen

First Received on March 13, 2009.   Last Updated on March 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperglycemia
Hyperglucagonemia
Glucose Intolerance
Additional conditions recognized in this trial
Diabetes Mellitus, Type 2
More general conditions related to this trial
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
GLP-1 infusion
Additional drug interventions recognized in this trial
Glucagon
Glucagon-Like Peptide 1
More general drug interventions related to this trial
Gastrointestinal Agents
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Incretins
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University Hospital, Gentofte, Copenhagen
University of Copenhagen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services